Summary & Overview
HCPCS G9704: AJCC Breast Cancer Stage I (T1mi/T1a)
HCPCS Level II code G9704 identifies documentation of AJCC breast cancer stage I specifically recording tumor size categories T1mi or T1a. Accurate staging is a critical element in breast cancer care, guiding treatment planning, prognosis communication, and quality reporting. National attention on standardized staging documentation supports continuity across oncology practices, registries, and payers.
Key payers in national coverage discussions include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of the code's clinical meaning and common sites of service, plus context on how the code is used in administrative records. The publication summarizes benchmark considerations and policy-relevant points for payers and providers, outlines potential billing pathways where available, and highlights where input data is not available.
This analysis is intended to inform clinicians, billing professionals, and policy stakeholders about the role of G9704 in documenting early-stage breast cancer (T1mi/T1a), common care settings where the code appears, and the national payer environment that typically addresses staging documentation.
Billing Code Overview
HCPCS Level II code G9704 documents AJCC breast cancer stage I with tumor size T1mi or T1a. The code denotes a clinical staging classification indicating a very small invasive breast tumor (microscopic invasion or tumor ≤0.5 cm for T1mi; >0.1 cm up to 1 cm for T1a) and is used to record cancer stage in clinical and administrative records.
-
Service type: Cancer staging documentation and reporting
-
Typical site of service: Oncology clinics, hospital outpatient departments, and cancer centers
Clinical & Coding Specifications
Clinical Context
A 58-year-old woman undergoes diagnostic workup after a screening mammogram shows a suspicious 0.8 cm lesion in the upper outer quadrant of the right breast. Core needle biopsy returns invasive ductal carcinoma with features consistent with a small primary tumor. The multidisciplinary breast team documents AJCC breast cancer stage I, specifically T1a (tumor >0.1 cm but ≤0.5 cm) or T1mic (microinvasion ≤0.1 cm) in the operative and pathology reports. The clinical workflow includes preoperative staging, surgical planning (breast-conserving surgery or lumpectomy with sentinel lymph node biopsy), pathology confirmation of tumor size and margins, and documentation of AJCC stage in the chart to support quality reporting and registry submission. Typical sites of service are hospital outpatient surgical units or ambulatory surgical centers where oncologic breast surgery and pathology review occur. Common patient management steps include imaging (diagnostic mammography and ultrasound), biopsy, surgical resection with lymph node evaluation, postoperative pathology staging, and coordination with medical and radiation oncology for adjuvant treatment planning when indicated.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when work or resources for documentation, staging, or operative time substantially exceed typical expectations for staging documentation associated with breast surgery. |